Osteoporosis circumscripta cranii (also known as osteolysis circumscripta) refers to discrete radiolucent regions of the skull on plain radiographs. They are often seen in context of the lytic (incipient-active) phase of Paget's disease of the skull, but may be observed in other circumstances as well, e.g. hyperparathyroidism, leontiasis ossea 9.
Over time there has been some debate whether the term should be restricted to non-Pagetoid skull lesions or not 10-11. Just like contemporary literature 12-14 this article uses the term synonymously with the early phase of Paget disease of the skull.
Imaging appearances are those of:
- well-defined areas of radiolucency, often large
- most commonly located in frontal and occipital bones
- affecting both inner and outer calvarial tables, with changes in outer table usually more extensive
In patients with simultaneous halisteretic metabolic bone changes, e.g. osteoporosis identification of above mentioned changes may be challenging.
Bony changes are largely identical to those depicted in radiographic findings. Attenuation values of bone marrow space in affected areas are often those of macroscopic fat.
As Paget disease most often presents as a continuum rather than distinct phase, sclerotic areas of the blastic (mixed) phase may more readily be detected. They usually present as cortical and trabecular thickening in a disorganised pattern without bony destruction.
Cortical changes are more readily appreciated on plain film or CT.
Typical bone marrow changes in the incipient-active to early mixed phase show heterogenous signal on both T1 and T2-weighted imaging 3:
- T1: decreased signal intensity, isointense to muscle, with interspersed foci of normal signal representing maintained yellow marrow (usable criterion to exclude malignant transformation)
- T2: high intensity changes, heterogeneous and of "speckled" appearance, possibly presenting fibrovascular marrow changes
- C+ (Gd): enhancement, typically of "speckled" appearance, may be present, indicating increased blood flow in the metabolically active sites
Bone-seeking tracers (Tc99m conjugated bisphosphonates, typically MDP) show intense uptake in this early form of Paget´s disease. Additional sites (polyostotic disease) may be revealed in up to 30% of cases 6.
In polyostotic disease discrepancy between morphological (CT) and pathophysiological changes (SPECT) especially in early and late stages should not lead to confusion and are well-described in literature 3,5.
Non-FDG PET/CT (F18-NaF)
Owing to both higher bone uptake of this tracer combined with superior imaging quality (higher signal-to-noise ratio SNR due to faster blood clearance, higher spatial resolution of PET) compared to SPECT (see above,) intensity of uptake is even higher and polyostotic disease may be even more evident 5,7.
Early phase Paget disease of the skull usually lacks FDG-avidity 8.
Encountering a lytic bone lesion (also resembling osteolysis circumscripta) in oncological patients may pose a differential diagnostic dilemma. Finding normal FDG-metabolism may aid in the diagnosis of benign Paget's disease and obviate the need for biopsy 5.
On plain radiograph consider:
Metabolic bone disease
- bone mineralisation
- pituitary gland-related
- thyroid gland-related
- osteosclerosis (differential diagnosis | mnemonic)
- 1. Frame B, Marel GM. Paget disease: a review of current knowledge. Radiology. 1981;141 (1): 21-4. Radiology (abstract) - Pubmed citation
- 2. Love C, Din AS, Tomas MB et-al. Radionuclide bone imaging: an illustrative review. Radiographics. 23 (2): 341-58. doi:10.1148/rg.232025103 - Pubmed citation
- 3. Smith SE, Murphey MD, Motamedi K et-al. From the archives of the AFIP. Radiologic spectrum of Paget disease of bone and its complications with pathologic correlation. Radiographics. 22 (5): 1191-216. Radiographics (full text) - Pubmed citation
- 4. Cook GJ, Maisey MN, Fogelman I. Fluorine-18-FDG PET in Paget's disease of bone. J. Nucl. Med. 1997;38 (9): 1495-7. Pubmed citation
- 5. Chakraborty D, Mittal BR, Kamaleshwaran KK et-al. Urinary bladder carcinoma associated with Paget's disease of skull: Imaging findings on Tc99m-MDP bone scintigraphy, F18-Fluoride PET/CT and F18-FDG PET/CT. Indian J Nucl Med. 2013;26 (1): 42-3. Free text at pubmed - Pubmed citation
- 6. Vellenga CJ, Bijvoet OL, Pauwels EK. Bone scintigraphy and radiology in Paget's disease of bone: a review. Am J Physiol Imaging. 1989;3 (3): 154-68. Pubmed citation
- 7. Li Y, Schiepers C, Lake R et-al. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone. 2012;50 (1): 128-39. doi:10.1016/j.bone.2011.09.053 - Pubmed citation
- 8. Cook GJ, Maisey MN, Fogelman I. Fluorine-18-FDG PET in Paget's disease of bone. J. Nucl. Med. 1997;38 (9): 1495-7. Pubmed citation
- 9. Windholz F, Osteoporosis Circumscripta Cranii: Its Pathogenesis and Occurrence in Leontiasis Ossea and in Hyperparathyroidism, Radiographics Jan 1945, http://pubs.rsna.org/doi/abs/10.1148/44.1.14
- 10. Karani S. Osteoporosis circumscripta cranii. Br J Clin Pract. 2000;12 (2): 111-2. Pubmed citation
- 11. Bossi R, Pisani G. Is osteoporosis circumscripta cranii (Schüller disease II) a separate entity from osteolytic Paget skull dystrophy?. Br J Radiol. 2002;29 (344): 445-9. Pubmed citation
- 12. Resnick D, Kransdorf M. Bone and joint imaging. Saunders. ISBN:0721602703. Read it at Google Books - Find it at Amazon Ch. 43
- 13. Grainger & Allison's diagnostic radiology essentials. Churchill Livingstone. ISBN:0702034487. Read it at Google Books - Find it at Amazon 5.5 pp. 556-575
- 14. Som PM, Curtin HD. Head and Neck Imaging - 2 Volume Set. Mosby. ISBN:0323053556. Read it at Google Books - Find it at Amazon Ch. 19, pp. 1231-1261